Loading stock data…
ICU
$4.37+0.23 (+5.56%)
Market ClosedLast close May 1
SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
SeaStar Medical Holding Corporation in the Healthcare sector is trading at $4.37. The stock is currently 67% below its 52-week high of $13.40, remaining 8.4% below its 200-day moving average. Technical signals show neutral RSI of 53 and bearish MACD signal, explaining why ICU maintains its current current market pressure. The Whystock Score of 15/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 53) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$4.37
Potential Upside
5%
Whystock Fair Value$4.59
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytophereti...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$17.11M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
-1.19
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-41.58%
Volume
Today's trading volume
110,961
Recent News
SeaStar Medical Holding Corp (ICU) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...
SeaStar Medical Holding Corp (ICU) reports significant revenue growth and customer base expansion, while navigating financial hurdles and regulatory challenges in its Q4 2025 earnings call.
SeaStar Medical Holding Corp (ICU) Q3 2025 Earnings Call Highlights: Revenue Surge and ...
SeaStar Medical Holding Corp (ICU) reports a 45% revenue increase and strategic growth in pediatric hospitals, while addressing trial enrollment challenges and revenue variability.
SeaStar Medical (ICU) Q3 2025 Earnings Transcript
Eric Schlorff: Thank you, Jackie, and thank you all for joining us today. Since the beginning of the third quarter, we advanced our business on several fronts that we believe position us well for our future growth.
SeaStar Medical Holding Corp (ICU) Q2 2025 Earnings Call Highlights: Record Revenue Growth and ...
SeaStar Medical Holding Corp (ICU) reports a 370% revenue increase and significant clinical trial progress, despite challenges in customer adoption and operating expenses.
Top Midday Gainers
Plus Therapeutics (PSTV) said Wednesday that the US Food and Drug Administration has cleared its inv